Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”
International Journal of Rheumatic Diseases · 2026-11 · 29 (11)
DOI: 10.1111/1756-185x.70942 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 28.10.2026. Verfasst von Bodhisatwa Choudhuri. Beteiligte Einrichtung: Department of Critical Care, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Critical Care, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
- Department of Critical Care, Emergency Medicine & Rheumatology, Parkview Super-Specialty Hospital, Kolkata, West Bengal, India.
ORCID-Profile: Bodhisatwa Choudhuri
Zitieren
APA
Choudhuri, B. (2026). Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”. International Journal of Rheumatic Diseases, 29(11). https://doi.org/10.1111/1756-185x.70942
Vancouver
Choudhuri B. Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”. International Journal of Rheumatic Diseases. 2026;29(11). doi:10.1111/1756-185x.70942
BibTeX
@article{Choudhuri2026,
author = {Choudhuri, Bodhisatwa},
title = {Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
volume = {29},
number = {11},
doi = {10.1111/1756-185x.70942}
}
EUVIMED